Moreover, anti-blockade of PD-1/PD-L1 immune checkpoints in an AT-84-E7 murine model of HNSCC led to tumor enlargement by depleting B cells in the tumor microenvironment by regulating B cell activation and germinal center formation (Kim et al., 2020). The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.